[
  {
    "ts": null,
    "headline": "Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)",
    "summary": "Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential. Click for this MRK earnings update.",
    "url": "https://finnhub.io/api/news?id=24abefe2dde0dd6cb08ed49074d7631736975bd6c3a5e485d88a285fe9510255",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738680260,
      "headline": "Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)",
      "id": 132553800,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1009832978/image_1009832978.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential. Click for this MRK earnings update.",
      "url": "https://finnhub.io/api/news?id=24abefe2dde0dd6cb08ed49074d7631736975bd6c3a5e485d88a285fe9510255"
    }
  }
]